|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1998-10-26
|
|
pubmed:abstractText |
To evaluate the efficacy of an abbreviated treatment plan consisting of two cycles of chemotherapy plus thoracic irradiation in a population of limited-stage small-cell lung cancer (LSCLC) patients who were elderly, infirm, or noncompliant with standard-duration therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3323-8
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:9779708-Aged,
pubmed-meshheading:9779708-Aged, 80 and over,
pubmed-meshheading:9779708-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9779708-Carcinoma, Small Cell,
pubmed-meshheading:9779708-Cisplatin,
pubmed-meshheading:9779708-Combined Modality Therapy,
pubmed-meshheading:9779708-Cyclophosphamide,
pubmed-meshheading:9779708-Doxorubicin,
pubmed-meshheading:9779708-Etoposide,
pubmed-meshheading:9779708-Female,
pubmed-meshheading:9779708-Humans,
pubmed-meshheading:9779708-Lung Neoplasms,
pubmed-meshheading:9779708-Male,
pubmed-meshheading:9779708-Middle Aged,
pubmed-meshheading:9779708-Survival Rate,
pubmed-meshheading:9779708-Treatment Refusal,
pubmed-meshheading:9779708-Vincristine
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Abbreviated treatment for elderly, infirm, or noncompliant patients with limited-stage small-cell lung cancer.
|
|
pubmed:affiliation |
Lung Tumor Group, Vancouver Center, British Columbia Cancer Agency, Canada. nmurray@bccancer.bc.ca
|
|
pubmed:publicationType |
Journal Article
|
